Literature DB >> 19630109

Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

Arjuna Priyadarsin de Silva1, Aranjan Lionel Karunanayake, Thalahitiya Gamaralalage Iruka Dissanayaka, Anuradha Supun Dassanayake, Hewa Kattadi Kankanamgae Tilak Duminda, Arunasalam Pathmeswaran, Ananda Rajitha Wickramasinghe, Hithanadura Janaka de Silva.   

Abstract

AIM: To determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in adult Sri Lankans.
METHODS: We identified eligible subjects from among consecutive patients diagnosed with IBD who attended our outpatient clinic. We included only patients aged between 20 and 70 years. Patients who were pregnant, had significant comorbidity, or were on calcium supplements or treatment for osteoporosis within the past 6 mo, were excluded. Healthy, age- and sex-matched controls were also recruited, in a control to patient ratio of 3:1. Both groups were screened for osteoporosis using peripheral dual energy X-ray absorptiometry scanning.
RESULTS: The study population consisted of 111 IBD patients (male:female = 43:68; mean age 42.5 years) and 333 controls (male:female = 129:204; mean age 43.8 years). The occurrence of osteoporosis among IBD patients (13.5%) was significantly higher than among controls (4.5%) (P = 0.001). The frequency of osteoporosis was not significantly different between ulcerative colitis (14.45%) and Crohn's disease (10.7%). However, on multivariate analysis, only age (P = 0.001), menopause (P = 0.024) and use of systemic steroids (P < 0.001) were found to be associated independently with the occurrence of osteoporosis, while IBD, severity of disease, number of relapses, duration of illness or treatment other than systemic steroids were not.
CONCLUSION: IBD does not appear to be an independent risk factor for the occurrence of osteoporosis in this population. However, the use of systemic steroids was a risk factor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630109      PMCID: PMC2715980          DOI: 10.3748/wjg.15.3528

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Osteoporosis in patients with inflammatory bowel disease.

Authors:  N K Arden; C Cooper
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  Prevention and treatment of osteoporosis in inflammatory bowel disease.

Authors:  Gary R Lichtenstein; Bruce E Sands; Michael Pazianas
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

3.  Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review.

Authors:  Bridget P Sinnott; Angelo A Licata
Journal:  Endocr Pract       Date:  2006 Nov-Dec       Impact factor: 3.443

Review 4.  A 2008 panorama on osteoporosis and inflammatory bowel disease.

Authors:  N Sapone; R Pellicano; D Simondi; C Sguazzini; S Reggiani; E Terzi; M Rizzetto; M Astegiano
Journal:  Minerva Med       Date:  2008-02       Impact factor: 4.806

5.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Authors:  S Ardizzone; S Bollani; P Bettica; M Bevilacqua; P Molteni; G Bianchi Porro
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

6.  Genetic factors determine extent of bone loss in inflammatory bowel disease.

Authors:  C M Schulte; A U Dignass; H Goebell; H D Röher; K M Schulte
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

7.  A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.

Authors:  Sandra Henderson; Neville Hoffman; Richard Prince
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

Review 8.  Emergence of inflammatory bowel disease 'beyond the West': do prosperity and improved hygiene have a role?

Authors:  H J de Silva; N R de Silva; A P de Silva; D P Jewell
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-05-02       Impact factor: 2.184

Review 9.  The pathophysiology of bone disease in gastrointestinal disease.

Authors:  Charles N Bernstein; William D Leslie
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 2.566

Review 10.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

View more
  5 in total

1.  The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Authors:  Levent Ediz; Ahmet Cumhur Dülger; Murat Toprak; Mehmet Fethi Ceylan; Ozgür Kemik
Journal:  Int J Clin Exp Med       Date:  2011-04-03

2.  Correlation between low bone density and disease activity in patients with ulcerative colitis.

Authors:  Taghi Amiriani; Sima Besharat; Zahra Pourramezan; Honey Sadat Mirkarimi; Mehrdad Aghaei; Hamidreza Joshaghani; Gholamreza Roshandel; Maryam Faghani; Mahsa Besharat
Journal:  Middle East J Dig Dis       Date:  2015-01

3.  Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain.

Authors:  José Miranda-Bautista; Cristina Verdejo; Alicia Díaz-Redondo; Irene Bretón; José M Bellón; María Dolores Pérez-Valderas; Aránzazu Caballero-Marcos; Marta de Dios-Lascuevas; Elena González-Río; Cristina García-Sánchez; Ignacio Marín-Jiménez; Rafael Bañares; Luis Menchén
Journal:  Therap Adv Gastroenterol       Date:  2019-07-31       Impact factor: 4.409

Review 4.  Bone alterations in inflammatory bowel diseases.

Authors:  Dolores Sgambato; Francesca Gimigliano; Cristiana De Musis; Antimo Moretti; Giuseppe Toro; Emanuele Ferrante; Agnese Miranda; Domenico De Mauro; Lorenzo Romano; Giovanni Iolascon; Marco Romano
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

5.  [The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors].

Authors:  Aida Ben Slama Trabelsi; Faouzi Abdellaoui; Mehdi Ksiaa; Ahlem Souguir; Hela Zeglaoui; Mohamed Ben Rejeb; Ahlem Brahem; Salem Ajmi; Ali Jmaa
Journal:  Pan Afr Med J       Date:  2013-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.